Jan. 11, 2019
According to a recent announcement from Chinese company Lier Chemical
, its Guang’an glufosinate trial production has resumed. In its Guang’an production base, Lier Chemical has completed construction of a 3,000-ton glufosinate capacity and 1,000-ton flumioxazin capacity. In 2019, a 1,000-ton epoxiconazole production capacity is scheduled to begin production.
The demand for Glufosinate is growing rapidly and its supply and demand situation in 2019 will remain in balance with a slight reduction in supply. In the first ten months of 2018, China’s export of glufosinate reached 7,018 tons, which is expected to touch nearly 10,000 tons in the whole of 2018, to be 69% up year on year.